Ferrulli and colleagues ran a randomized, sham-controlled trial of 33 adults with obesity: deep TMS targeting the PFC and insula for five weeks produced significant weight loss that persisted at 12-month follow-up [16]
Although research is still very much in its infancy for the use of GLP1-agonists with non-diabetics, what is clear is that these drugs do not come without a myriad of risks, as one would expect with any novel miracle drug promising quick results
Check Your Meds: If you take prescription medications for diabetes or high blood pressure, talk to your doctor first
Perfect scores across all seven transparency categories: authentic images, accurate advertising, proactive disclaimers about compounded medications, and easy cancellation
The single most important thing: the membership fee, not the headline price, usually decides your real annual cost
Linda Anegawa